XORTX Therapeutics Inc. reported a Form 6-K filing acknowledging their registration under the Securities Exchange Act on January 2, 2024, and confirmed the filing of annual reports under Form 20-F.
AI Assistant
XORTX THERAPEUTICS INC
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.